These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9167004)

  • 21. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.
    Chumakov KM; Norwood LP; Parker ML; Dragunsky EM; Ran YX; Levenbook IS
    J Virol; 1992 Feb; 66(2):966-70. PubMed ID: 1309923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan.
    Yoshida H; Horie H; Matsuura K; Miyamura T
    Lancet; 2000 Oct; 356(9240):1461-3. PubMed ID: 11081527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
    Dragunsky E; Nomura T; Karpinski K; Furesz J; Wood DJ; Pervikov Y; Abe S; Kurata T; Vanloocke O; Karganova G; Taffs R; Heath A; Ivshina A; Levenbook I
    Bull World Health Organ; 2003; 81(4):251-60. PubMed ID: 12764491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H
    J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing.
    Sarcey E; Serres A; Tindy F; Chareyre A; Ng S; Nicolas M; Vetter E; Bonnevay T; Abachin E; Mallet L
    J Virol Methods; 2017 Aug; 246():75-80. PubMed ID: 28456668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Next-Generation Sequencing for the Quality Control of Live-Attenuated Polio Vaccines.
    Charlton B; Hockley J; Laassri M; Wilton T; Crawt L; Preston M; ; Rigsby P; Chumakov K; Martin J
    J Infect Dis; 2020 Nov; 222(11):1920-1927. PubMed ID: 32492703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.
    Gnanashanmugam D; Falkovitz-Halpern MS; Dodge A; Fang M; Wong LJ; Esparza M; Hammon R; Rivas-Merelles EE; Santos JI; Maldonado Y
    J Clin Microbiol; 2007 Aug; 45(8):2419-25. PubMed ID: 17581940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K; Norwood L; Parker M; Dragunsky E; Taffs R; Ran Y; Ridge J; Levenbook I
    Dev Biol Stand; 1993; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
    Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.
    Davis LE; Bodian D; Price D; Butler IJ; Vickers JH
    N Engl J Med; 1977 Aug; 297(5):241-5. PubMed ID: 195206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects.
    Fenyves A
    Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826
    [No Abstract]   [Full Text] [Related]  

  • 33. Laboratory tests for live attenuated poliovirus vaccine.
    Arya SC
    Biologicals; 1998 Sep; 26(3):245-6. PubMed ID: 10208726
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
    Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Nagata N; Kew O; Miyamura T
    Dev Biol (Basel); 2001; 105():93-8. PubMed ID: 11763343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
    Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of mutations in oral poliovirus vaccine by hybridization with generic oligonucleotide microchips.
    Proudnikov D; Kirillov E; Chumakov K; Donlon J; Rezapkin G; Mirzabekov A
    Biologicals; 2000 Jun; 28(2):57-66. PubMed ID: 10885613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the role of the World Health Organization in the development of Sabin vaccines.
    Magrath D; Reeve P
    Biologicals; 1993 Dec; 21(4):345-8. PubMed ID: 8024749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
    Rezapkin GV; Alexander W; Dragunsky E; Parker M; Pomeroy K; Asher DM; Chumakov KM
    Virology; 1998 Jun; 245(2):183-7. PubMed ID: 9636357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
    Chumakov KM; Powers LB; Noonan KE; Roninson IB; Levenbook IS
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):199-203. PubMed ID: 1846038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches to poliovirus diagnosis using laboratory techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1992; 70(1):27-33. PubMed ID: 1348972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.